Table 1.

Baseline characteristics of included participants according to the follow-up outcome

Variables	No NAFLD (n=41 033）	NAFLD (n=5660）	P value
Men, n (%)*	20 799 (50.69)	2033 (35.92)	<0.001
Age (years)†	69.18±7.27	66.93±6.00	<0.001
Current smoking, n (%)*	6846 (16.70)	594 (10.51)	<0.001
Exercise, n (%)*	7865 (19.22)	1131 (20.02)	<0.001
Live alone, n (%)*	8772 (21.38)	1015 (17.93)	<0.001
Diabetes, n (%)*	5554 (13.54)	1344 (23.75)	<0.001
Hypertension, n (%)*	15 945 (38.86)	2952 (52.16)	<0.001
WHtR†	0.51±0.06	0.54±0.07	<0.001
BMI†	23.62±2.85	26.02±3.10	<0.001
SBP (mm Hg)†	132.62±19.38	135.32±19.76	<0.001
DBP (mm Hg)†	78.92±10.34	80.91±10.33	<0.001
FPG (mmol/L)‡	5.20 (4.70 to 5.70)	5.30 (4.80 to 5.93)	<0.001
TC (mmol/L)‡	4.59 (4.01 to 5.21)	4.69 (4.09 to 5.38)	<0.001
TG (mmol/L)‡	1.10 (0.81 to 1.47)	1.28 (0.90 to 1.77)	<0.001
TB (μmol/L)‡	11.51 (8.60 to 14.10)	11.30 (8.30 to 13.80)	<0.001
ALT(U/L)‡	18.00 (13.00 to 24.50)	18.60 (14.00 to 25.00)	<0.001
AST(U/L)‡	21.80 (16.89 to 26.90)	21.90 (16.89 to 27.00)	0.892
TyG‡	8.43±0.54	8.61±0.59	<0.001

*n (%).

†Mean (SD).

‡Median (IQR).

ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; NAFLD, non-alcoholic fatty liver disease; SBP, systolic blood pressure; TB, total bilirubin; TC, total cholesterol; TG, triglyceride; TyG, triglyceride glucose; WHtR, waist-to-height ratio.